Publications for Tove Sivik
Co-author map based on ISI articles 2007-
Journal Articles
Tove Sivik, Cecilia Gunnarsson, Tommy Fornander, Bo Nordenskjöld, Lambert Skoog, Olle Stål and Agneta Jansson
17β-hydroxysteroid dehydrogenase type 14 is a predictive marker for tamoxifen response in oestrogen receptor positive breast cancer
PLoS ONE, 2012, 7(7), e40568.
Web of Science® Times Cited: 1 |
Tove Sivik and Agneta Jansson
Progesterone and levonorgestrel regulate expression of 17 beta HSD-enzymes in progesterone receptor positive breast cancer cell line T47D
Biochemical and Biophysical Research Communications - BBRC, 2012, 422(1), 109-113.
Fulltext  |
Tove Sivik, Svante Vikingsson, Henrik Gréen and Agneta Jansson
Expression Patterns of 17β-Hydroxysteroid Dehydrogenase 14 in Human Tissues
Hormone and Metabolic Research, 2012, 44(13), 949-956.
|
Tove Sivik, Svante Vikingsson, Henrik Greén and Agneta Jansson
A validated and rapid high-performance liquidchromatography method for the quantification ofconversion of radio-labelled sex steroids
Hormone Molecular Biology and Clinical Investigation, 2010, 3(1), 375-381.
|
Agneta Jansson, Cecilia Gunnarsson, Maja Cohen, Tove Sivik and Olle Stål
17β-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer
Cancer Research, 2006, 66(23), 11471-11477.
Web of Science® Times Cited: 29 |
Conference Articles
Ph.D. Theses
Ph.D., Lic. Theses
